Caprotec Bioanalytics Raises €4 Nillion

Caprotec Bioanalytics, a Berlin, Germany-based developer of capture compound mass spectrometry technology, has raised €4 million in Series B funding. Return backers include Creathor Venture, IBB Beteiligungsgesellschaft and ERP Startfonds.

17 May 2010•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail